pDONR223-RPS6KA2 Citations (2)
Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal
Articles Citing pDONR223-RPS6KA2
| Articles |
|---|
| Quantitative in vivo fluorescence cross-correlation analyses highlight the importance of competitive effects in the regulation of protein-protein interactions. Sadaie W, Harada Y, Matsuda M, Aoki K. Mol Cell Biol. 2014 Sep;34(17):3272-90. doi: 10.1128/MCB.00087-14. Epub 2014 Jun 23. PubMed |
| Proteome-wide analysis of phospho-regulated PDZ domain interactions. Sundell GN, Arnold R, Ali M, Naksukpaiboon P, Orts J, Guntert P, Chi CN, Ivarsson Y. Mol Syst Biol. 2018 Aug 20;14(8):e8129. doi: 10.15252/msb.20178129. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.